Compare Crocs, Inc. (CROX) vs Quest Diagnostics Inc (DGX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Crocs, Inc. vs Quest Diagnostics Inc — how do they compare? Crocs, Inc. trades at $131.61 (market cap $6.63B), while Quest Diagnostics Inc trades at $237.5 (market cap $26.23B). The key difference: Quest Diagnostics Inc is far larger — about 4× Crocs, Inc.'s market cap, and Quest Diagnostics Inc pays a 1.45% dividend while Crocs, Inc. pays none. Which is the better fit depends on your goals.
| CROX | DGX | |
|---|---|---|
Market Cap | $6.63B | $26.23B |
Sector | Consumer Staples | Health |
52-Week High | $141.19 | $238.50 |
52-Week Low | $73.39 | $173.49 |
Enterprise Value | $8.14B | $31.99B |
Dividend Yield | — | 1.45% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Crocs, Inc.
Crocs Inc is engaged in the design, development, marketing, distribution, and sale of casual lifestyle footwear accessories for men, women, and children. The reportable geographic segments of the company include Americas, Asia pacific, and EMEA.
Read more on CROX →About Quest Diagnostics Inc
Quest Diagnostics is a leading independent provider of diagnostic testing, information, and services in the U.S. The company generates over 95% of its revenue through clinical testing, anatomic pathology, esoteric testing, and substance abuse testing with specimens collected at its national network of roughly 2,300 patient service centers, as well as multiple doctors offices and hospitals. The firm also runs a much smaller diagnostic solutions segment that provides clinical trials testing, risk assessment services, and information technology solutions.
Read more on DGX →
